Literature DB >> 30721125

Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Underused across the 49th parallel.

Michael J Raphael1,2, Christopher M Booth1,2,3.   

Abstract

Entities:  

Year:  2019        PMID： 30721125      PMCID： PMC6363561          DOI： 10.5489/cuaj.5827

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  22 in total

Review 1.  A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma.

Authors:  Jeffrey J Leow; William Martin-Doyle; André P Fay; Toni K Choueiri; Steven L Chang; Joaquim Bellmunt
Journal:  Eur Urol       Date:  2014-03-16       Impact factor: 20.096

2.  Adjuvant chemotherapy in muscle-invasive bladder carcinoma: a pooled analysis from phase III studies.

Authors:  Enzo Maria Ruggeri; Diana Giannarelli; Emilio Bria; Paolo Carlini; Alessandra Felici; Fabrizio Nelli; Michele Gallucci; Francesco Cognetti; Camillo Francesco Pollera
Journal:  Cancer       Date:  2006-02-15       Impact factor: 6.860

3.  A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy.

Authors:  Matthew D Galsky; Noah M Hahn; Jonathan Rosenberg; Guru Sonpavde; Thomas Hutson; William K Oh; Robert Dreicer; Nicholas Vogelzang; Cora Sternberg; Dean F Bajorin; Joaquim Bellmunt
Journal:  Lancet Oncol       Date:  2011-03       Impact factor: 41.316

4.  The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada.

Authors:  Christopher M Booth; Gavin Li; Jina Zhang-Salomons; William J Mackillop
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

5.  Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Authors: 
Journal:  Eur Urol       Date:  2005-04-21       Impact factor: 20.096

6.  Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process.

Authors:  Jo-An Seah; Normand Blais; Scott North; Yasmin Rahim; Dean Ruether; Peter C Black; Alexandre R Zlotta; Lori Wood; Srikala S Sridhar
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

7.  Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial.

Authors:  F Cognetti; E M Ruggeri; A Felici; M Gallucci; G Muto; C F Pollera; B Massidda; A Rubagotti; D Giannarelli; F Boccardo
Journal:  Ann Oncol       Date:  2011-08-22       Impact factor: 32.976

8.  International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

Authors:  Gareth Griffiths; Reginald Hall; Richard Sylvester; Derek Raghavan; Mahesh K B Parmar
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

9.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Authors:  H Barton Grossman; Ronald B Natale; Catherine M Tangen; V O Speights; Nicholas J Vogelzang; Donald L Trump; Ralph W deVere White; Michael F Sarosdy; David P Wood; Derek Raghavan; E David Crawford
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

Review 10.  Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

Authors: 
Journal:  Lancet       Date:  2003-06-07       Impact factor: 79.321
View more
  4 in total

Review 1.  Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review.

Authors:  Biagio Barone; Armando Calogero; Luca Scafuri; Matteo Ferro; Giuseppe Lucarelli; Erika Di Zazzo; Enrico Sicignano; Alfonso Falcone; Lorenzo Romano; Luigi De Luca; Francesco Oliva; Benito Fabio Mirto; Federico Capone; Ciro Imbimbo; Felice Crocetto
Journal:  Cancers (Basel)       Date:  2022-05-21       Impact factor: 6.575

2.  The use of perioperative chemotherapy in patients undergoing radical cystectomy for bladder cancer in Quebec, Canada, 2000-2016.

Authors:  Michel D Wissing; Wassim Kassouf; Simon Tanguay; Armen G Aprikian
Journal:  Can Urol Assoc J       Date:  2019-11-29       Impact factor: 1.862

3.  Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2019.

Authors:  Luka Flegar; K Kraywinkel; A Zacharis; C Aksoy; R Koch; N Eisenmenger; C Groeben; J Huber
Journal:  World J Urol       Date:  2022-04-29       Impact factor: 3.661

Review 4.  Imaging and Management of Bladder Cancer.

Authors:  Vincenzo K Wong; Dhakshinamoorthy Ganeshan; Corey T Jensen; Catherine E Devine
Journal:  Cancers (Basel)       Date:  2021-03-19       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.